These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 7146024

  • 1. The membrane lesion and its treatment in sickle cell anemia.
    Brewer GJ, Wetterstroem N, Mitchinson A, Brewer LF.
    Prog Clin Biol Res; 1982; 98():91-6. PubMed ID: 7146024
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detours on the road to successful treatment of sickle cell anemia.
    Brewer GJ.
    Perspect Biol Med; 1979; 22(2 Pt 1):250-72. PubMed ID: 379797
    [No Abstract] [Full Text] [Related]

  • 6. Disorders of erythrocyte cation permeability and water content associated with hemolytic anemia.
    Mentzer WC, Clark MR.
    Biomembranes; 1983; 11():79-118. PubMed ID: 6338953
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of cellular determinants and plasma factors responsible for increased adherence of sickle cells to vascular endothelium.
    Mohandas N, Evans E.
    Prog Clin Biol Res; 1987; 240():181-90. PubMed ID: 3615486
    [No Abstract] [Full Text] [Related]

  • 9. Erythrocyte reduced glutathione level in sickle cell anaemia and glucose-6-phosphate dehydrogenase deficient Saudi subjects.
    al-Ali AK.
    Ann Clin Biochem; 1994 May; 31 ( Pt 3)():296-7. PubMed ID: 8067674
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Abnormal dark adaptation in sickle cell anemia.
    Warth JA, Prasad AS, Zwas F, Frank RN.
    J Lab Clin Med; 1981 Aug; 98(2):189-94. PubMed ID: 7252330
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of phosphatidylserine in recognition and removal of erythrocytes.
    Kuypers FA, de Jong K.
    Cell Mol Biol (Noisy-le-grand); 2004 Mar; 50(2):147-58. PubMed ID: 15095785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Erythrocyte membrane protein changes in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease: an example of postsynthetic modification of membrane proteins.
    Allen DW, Flynn TP, Johnson GJ.
    Prog Clin Biol Res; 1982 Mar; 97():33-43. PubMed ID: 7156168
    [Abstract] [Full Text] [Related]

  • 17. Molecular mechanisms of zinc action on cells.
    Brewer GJ.
    Agents Actions Suppl; 1981 Mar; 8():37-49. PubMed ID: 7008558
    [Abstract] [Full Text] [Related]

  • 18. Erythrocyte membrane abnormalities in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean and A-types.
    Rice-Evans C, Rush J, Omorphos SC, Flynn DM.
    FEBS Lett; 1981 Dec 21; 136(1):148-52. PubMed ID: 7319058
    [No Abstract] [Full Text] [Related]

  • 19. Calmodulin and the red cell membrane.
    Brewer GJ, Dick RD, Aster JC, Hebbel RP.
    Prog Clin Biol Res; 1982 Dec 21; 97():25-31. PubMed ID: 6818559
    [No Abstract] [Full Text] [Related]

  • 20. Orientation of sickle red blood cells in an alternating electric field.
    Vienken J, Zimmermann U, Alonso A, Chapman D.
    Naturwissenschaften; 1984 Mar 21; 71(3):158-60. PubMed ID: 6728034
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.